These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 28873108)

  • 1. Phototherapy coding and documentation in the time of biologics.
    Rogers HW
    Cutis; 2017 Jul; 100(1):41-42. PubMed ID: 28873108
    [No Abstract]   [Full Text] [Related]  

  • 2. Phototherapy of psoriasis in the era of biologics: still in.
    Benáková N
    Acta Dermatovenerol Croat; 2011; 19(3):195-205. PubMed ID: 21933648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do utilization management controls for phototherapy increase the prescription of biologics?
    Simpson GL; Yelverton CB; Rittenberg S; Feldman SR
    J Dermatolog Treat; 2006; 17(6):359-61. PubMed ID: 17853310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors Associated with Receiving Biologics or Classic Systemic Therapy for Moderate-to-Severe Psoriasis: Evidence from the PSONET Registries.
    Davila-Seijo P; Garcia-Doval I; Naldi L; Cazzaniga S; Augustin M; Rustenbach SJ; Daudén E; Dam TN; Baker C; Spuls PI; Stern RS; Cohen AD
    Acta Derm Venereol; 2017 Apr; 97(4):516-518. PubMed ID: 27882386
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of phototherapy in the era of biologics.
    Torres AE; Lyons AB; Hamzavi IH; Lim HW
    J Am Acad Dermatol; 2021 Feb; 84(2):479-485. PubMed ID: 32339702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A U.K. multicentre audit of the assessment and management of psoriasis in children.
    Lam ML; Burden-Teh E; Taibjee SM; Taylor A; Webster S; Dolman S; Jury C; Caruana D; Darne S; Carmichael A; Natarajan S; McPherson T; Moore A; Katugampola R; Kalavala M; Al-Ismail D; Richards L; Jones V; Batul Syed S; Glover M; Hughes J; Anderson E; Hughes B; Babakinejad P; Murphy R
    Br J Dermatol; 2015 Mar; 172(3):789-92. PubMed ID: 25308153
    [No Abstract]   [Full Text] [Related]  

  • 7. Paradoxical effects of cost reduction measures in managed care systems for treatment of severe psoriasis.
    Yentzer BA; Yelverton CB; Simpson GL; Simpson JF; Hwang W; Balkrishnan R; Feldman SR
    Dermatol Online J; 2009 Apr; 15(4):1. PubMed ID: 19450394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Systemic therapy of psoriasis].
    Altmeyer P; Nüchel C
    Dtsch Med Wochenschr; 1996 Dec; 121(51-52):1605-7. PubMed ID: 9011488
    [No Abstract]   [Full Text] [Related]  

  • 9. The burden of illness associated with psoriasis: cost of treatment with systemic therapy and phototherapy in the US.
    Crown WH; Bresnahan BW; Orsini LS; Kennedy S; Leonardi C
    Curr Med Res Opin; 2004 Dec; 20(12):1929-36. PubMed ID: 15701211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phototherapy, psoriasis, and the age of biologics.
    Richard EG; Hönigsmann H
    Photodermatol Photoimmunol Photomed; 2014 Feb; 30(1):3-7. PubMed ID: 24313462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of ultraviolet (UV) transmission by emollients: relevance to narrowband UVB phototherapy and psoralen plus UVA photochemotherapy.
    Otman SG; Edwards C; Pearse AD; Gambles BJ; Anstey AV
    Br J Dermatol; 2006 May; 154(5):963-8. PubMed ID: 16634902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How are we using systemic drugs to treat psoriasis in children? An insight into current clinical U.K. practice.
    Burden-Teh E; Lam ML; Taibjee SM; Taylor A; Webster S; Dolman S; Jury C; Caruana D; Darne S; Carmichael A; Natarajan S; McPherson T; Moore A; Katugampola R; Kalavala M; Al-Ismail D; Richards L; Jones V; Batul Syed S; Glover M; Hughes J; Anderson E; Hughes B; Helbling I; Murphy R
    Br J Dermatol; 2015 Aug; 173(2):614-8. PubMed ID: 25601323
    [No Abstract]   [Full Text] [Related]  

  • 13. Undertreatment, treatment trends, and treatment dissatisfaction among patients with psoriasis and psoriatic arthritis in the United States: findings from the National Psoriasis Foundation surveys, 2003-2011.
    Armstrong AW; Robertson AD; Wu J; Schupp C; Lebwohl MG
    JAMA Dermatol; 2013 Oct; 149(10):1180-5. PubMed ID: 23945732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Would elimination of copayments for phototherapy decrease the cost of treating psoriasis with systemic biologics? A cost analysis.
    Simpson JF; Yelverton CB; Balkrishnan R; Fleischer A; Lide W; Feldman SR
    Manag Care Interface; 2006 Jun; 19(6):39-43. PubMed ID: 16892660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psoriasis treatment patterns of dermatologists in northeast Ohio.
    Grozdev I; Cao L; Kavlick K; Brodell RT; Mostow EN; Korman NJ
    J Cutan Med Surg; 2011; 15(3):157-61. PubMed ID: 21561584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining biologic therapies with other systemic treatments in psoriasis: evidence-based, best-practice recommendations from the Medical Board of the National Psoriasis Foundation.
    Armstrong AW; Bagel J; Van Voorhees AS; Robertson AD; Yamauchi PS
    JAMA Dermatol; 2015 Apr; 151(4):432-8. PubMed ID: 25517130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prescription of phototherapy in psoriasis].
    Beani JC
    Rev Prat; 2004 Jan; 54(1):43-7. PubMed ID: 15049599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phototherapy for psoriasis: what to choose and how to use: facts and controversies.
    Matz H
    Clin Dermatol; 2010; 28(1):73-80. PubMed ID: 20082955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoriasis treatment: traditional therapy.
    Lebwohl M; Ting PT; Koo JY
    Ann Rheum Dis; 2005 Mar; 64 Suppl 2(Suppl 2):ii83-6. PubMed ID: 15708945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost comparison of psoriasis treatments.
    Mikhael D; Babcock K; DesGroseilliers JP
    J Cutan Med Surg; 2009; 13(6):303-7. PubMed ID: 19919807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.